Phase I/II – Other

632 trials 274 recruiting

Filter these 632 trials by condition, country, sponsor and more.

Open in Search →

A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Pending

2025-523005-15-00 Non-Hodgkin Lymphoma
Evaluation of a new radiotracker for predicting complete response after neoadjuvant chemotherapy in HER2-positive early breast cancer Pending

2025-523286-23-00 Breast Cancer
Symbiotic-GU-06-A Study to Learn About the Study Medicine PF-08634404 Alone or In Combination With Enfortumab Vedotin in Adult Participants … Pending

2025-523523-21-00 Locally Advanced or Metastatic Urothelial Cancer
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally… Pending

2025-523524-53-00 ADVANCED OR METASTATIC RENAL CELL CARCINOMA
Symbiotic-GI-13, A Study to Learn About the Study Medicine Called PF-08634404 as Monotherapy and Combination Therapy in Adult Participants w… Pending

2025-523525-17-00 Unresectable Locally Advanced or Metastatic Hepatocellu
A Study to Learn about the Study Medicine called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers Pending

2025-523526-40-00 Advanced Solid Tumors
Study to assess how safe and effective is HRX215 in participants who underwent minor and major liver surgery due to colon carcinoma metastas… Pending

2025-523630-59-00 colon carcinoma metastases
A Basket Trial of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies Pending

2025-523774-16-00 Advanced malignancies
A Phase 1b/2 Study to Evaluate NB-4746 in Participants with Amyotrophic Lateral Sclerosis. Pending

2025-523939-18-00 Amyotrofic Lateral Sclerosis (ALS)
PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending

2025-524613-89-00 HER2 positive advanced breast cancer
Trial to study the safety and pharmacokinetics of ODM-212 combined with existing cancer treatments Pending

2025-524620-22-00 Neoplasms benign malignant and unspecified (incl. cysts
IL-1β blockade to prevent Immunothrombosis in recipients of a Pancreatic Organ (ILIPO) Pending

2025-524834-24-00 diabetic patients pancreatic transplant
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in… Pending

2025-525127-27-00 Generalized Myasthenia Gravis
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab… Pending

2026-525248-13-00 Advanced Solid Tumors
The headache- and migraine-inducing effects of pitolisant in women with migraine without aura Pending

2026-525521-20-00 Migraine without aura
A study to assess the long-term safety and clinical activity of mRNA-3927 in participants previously enrolled in the mRNA-3927-P101 study Pending

2022-502911-12-00 Propionic Acidemia
Clinical trial with dasatinib for the prevention of CAR-T side effects in patients with relapsed or treatment-resistant multiple myeloma und… Pending

2023-507537-16-00 Chimeric antigen receptor T cell therapy-associated cyt
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending

2024-516115-24-00 High risk relapsed neuroblastoma (relapsed or progresse
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus standard temozolomide … Pending

2024-516357-46-00 Glioblastoma
Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE) Pending

2024-516896-34-00 progressive/relapsed/refractory pediatric low-grade gli
Anti-CD 19 CAR-T cell therapy in patients with ANCA Vasculitis - the IDEAL trial Pending

2024-517303-36-00 ANCA-IgG-positive ANCA associated vasculitis
Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma pat… Pending

2024-518199-30-00 Soft tissue sarcoma patients
uPAR PET/MRI in glioma Pending

2024-519723-20-01 Glioma
A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell D… Pending

2024-519881-32-00 Sickle Cell Disease